- Home
- NOTE vs BYSI Comparison
NOTE vs BYSI Comparison
Compare NOTE & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTE
- BYSI
- Stock Information
- Founded
- NOTE 2013
- BYSI 2010
- Country
- NOTE United States
- BYSI United States
- Employees
- NOTE N/A
- BYSI N/A
- Industry
- NOTE EDP Services
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- NOTE Technology
- BYSI Health Care
- Exchange
- NOTE Nasdaq
- BYSI Nasdaq
- Market Cap
- NOTE 83.1M
- BYSI 73.4M
- IPO Year
- NOTE N/A
- BYSI 2017
- Fundamental
- Price
- NOTE $4.40
- BYSI $1.79
- Analyst Decision
- NOTE Strong Buy
- BYSI
- Analyst Count
- NOTE 4
- BYSI 0
- Target Price
- NOTE $29.25
- BYSI N/A
- AVG Volume (30 Days)
- NOTE 323.1K
- BYSI 21.4K
- Earning Date
- NOTE 11-11-2025
- BYSI 11-11-2025
- Dividend Yield
- NOTE N/A
- BYSI N/A
- EPS Growth
- NOTE N/A
- BYSI N/A
- EPS
- NOTE N/A
- BYSI N/A
- Revenue
- NOTE $109,683,000.00
- BYSI N/A
- Revenue This Year
- NOTE N/A
- BYSI N/A
- Revenue Next Year
- NOTE $42.27
- BYSI N/A
- P/E Ratio
- NOTE N/A
- BYSI N/A
- Revenue Growth
- NOTE N/A
- BYSI N/A
- 52 Week Low
- NOTE $3.80
- BYSI $0.98
- 52 Week High
- NOTE $24.36
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- NOTE 35.94
- BYSI 42.63
- Support Level
- NOTE $4.19
- BYSI $1.77
- Resistance Level
- NOTE $5.48
- BYSI $1.93
- Average True Range (ATR)
- NOTE 0.53
- BYSI 0.11
- MACD
- NOTE 0.05
- BYSI 0.01
- Stochastic Oscillator
- NOTE 33.52
- BYSI 36.36
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.